[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editor's Correspondence
January 12, 1998

Asymptomatic Mitral and Aortic Valve Disease Is Seen in Half of the Patients Taking ‘Phen-Fen'

Arch Intern Med. 1998;158(1):102. doi:

The combination of phentermine hydrochloride and fenfluramine hydrochloride, known as phen-fen, has been widely used for the treatment of exogenous obesity.1 The therapy has been highly successful. Up to 10 million obese people have been treated, reversing the trend in recent years toward increasing obesity in the US population. In 1996, the Food and Drug Administration approved dexfenfluramine hydrochloride for long-term monotherapy for obesity.

First Page Preview View Large
First page PDF preview
First page PDF preview